Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

Clinical trial NCT00802867 · COMPLETED

Trial details

NCT number: NCT00802867
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diphtheria Tetanus Pertussis Polio Haemophilus Infection

Start date: 2004-02-01
Primary completion: 2005-06-01
Enrollment: 989

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.